# Microsaic Systems Plc Research agreement with global biopharma partner

- Link: https://www.directorstalkinterviews.com/microsaic-systems-plc-research-agreement-global-biopharma-partner/412742020
- Published: 2017-12-13T07:18:11+00:00
- Author: Giles Arbor

**Microsaic Systems plc** (LON:MSYS), the developer of chip-based mass spectrometry
instruments, announces that it has signed a research agreement extending its collaboration
with a long standing global partner in the scale up and manufacture of biopharmaceutical
drugs. This amendment to the agreement has been entered into following the successful
completion of a collaboration stage contracted in a previous amendment announced
on 7 April 2017.

> **Glenn Tracey, CEO of Microsaic Systems plc, commented:** “We are delighted to
> agree this new phase of our collaboration with one of the foremost players in 
> the global market for scientific instrumentation, which is in line with the Company’s
> strategy to focus on application areas in bioprocessing and diagnostics. Since
> our previous announcement in April, in cooperation with the partner, we have demonstrated
> the technical feasibility of a specific biopharma application, and established
> the interest of end users. In this most recent contracted phase, which is expected
> to last into H2 2018, we will work closely with the partner to further integrate
> our MS technology with their world leading purification equipment. Our goal is
> that this will be followed by full product development and launch. If this goal
> is realised, we estimate that this product alone will represent a major commercial
> opportunity for Microsaic. Additionally, we will be evaluating other potential
> applications with this partner.
> “I am pleased that with this extension and deepening of our collaboration, our
> partner is demonstrating confidence both in Microsaic’s MS technology, and in 
> the potential of miniature MS in the bioprocessing industry.”

Share on: